Literature DB >> 16557778

Immunogenicity of Ribonucleic Acid Preparations Obtained from Salmonella typhimurium.

M R Venneman1, N J Bigley, L J Berry.   

Abstract

Mice immunized with purified whole-cell ribonucleic acid (RNA), RNA from the bacterial "particulate" fraction, and ribosome-associated RNA obtained from Salmonella typhimurium were found to be resistant to subsequent challenge infection with virulent salmonellae. Chemically, the immunogenic nucleic acid fractions contained from 1 to 3% "contaminant" material defined (based on the mean of 19 different preparations) as protein (0.24%), deoxyribonucleic acid (0.43%), methyl pentose (0.64%), hexose (1.58%), and undefined carbohydrate (0.76%). Heptoses and lipoidal material were not detectable in any of the immunogenic preparations examined. Physically, the nucleic acid preparations, after analytical ultracentrifugation, exhibited three boundaries similar to those reported elsewhere in comparable systems: 4 to 5S, 16S, and 23S. An evaluation of the immunity induced by the ribosome-associated RNA established that the immune response was (i) comparable to that induced 15 days postimmunization with live salmonellae and by ribosomal vaccines, but greater at 30 days postimmunization than that in mice immunized with attenuated salmonellae; (ii) dependent on the quantity of immunogen administered; (iii) dependent on the size of the infective inocula; (iv) inhibited at 15 but not at 30 days postimmunization when the immunogenic nucleic acid preparations were incorporated into Freund's incomplete adjuvant, (v) reduced or lost by dialysis in relatively high or low immunizing doses, respectively; and (vi) unaffected by enzymatic treatment of the preparations with trypsin, deoxyribonuclease, Pronase plus pancreatic ribonuclease, or pancreatic ribonuclease alone. The possible mode of action of ribosome-associated RNA in inducing an immune response to subsequent challenge infection with the homologous organism is discussed.

Entities:  

Year:  1970        PMID: 16557778      PMCID: PMC415944          DOI: 10.1128/iai.1.6.574-582.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  STUDIES ON THE ADJUVANT ACTION OF BACTERIAL ENDOTOXINS ON ANTIBODY FORMATION. VI. ENHANCEMENT OF ANTIBODY FORMATION BY NUCLEIC ACIDS.

Authors:  K MERRITT; A G JOHNSON
Journal:  J Immunol       Date:  1965-03       Impact factor: 5.422

2.  Blood nucleases and infectious viral nucleic acids.

Authors:  R M HERRIOTT; J H CONNOLLY; S GUPTA
Journal:  Nature       Date:  1961-03-11       Impact factor: 49.962

3.  The immunizing activity against tuberculous infection in mice of enzymatically active particles isolated from extracts of Mycobacterium tuberculosis.

Authors:  G P YOUMANS; I MILLMAN; A S YOUMANS
Journal:  J Bacteriol       Date:  1955-11       Impact factor: 3.490

4.  On the use of chloramphenicol-inhibited systems for investigating RNA and protein synthesis.

Authors:  A I ARONSON; S SPIEGELMAN
Journal:  Biochim Biophys Acta       Date:  1958-07

5.  Spectrophotometric method for the determination of free pentose and pentose in nucleotides.

Authors:  Z DISCHE
Journal:  J Biol Chem       Date:  1949-11       Impact factor: 5.157

6.  IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

7.  Antibody formation initiated in vitro. II. Antibody synthesis in x-irradiated recipients of diffusion chambers containing nucleic acid derived from macrophages incubated with antigen.

Authors:  M FISHMAN; F L ADLER
Journal:  J Exp Med       Date:  1963-04-01       Impact factor: 14.307

8.  Infectivity of ribonucleic acid from poliovirus in human cell monolayers.

Authors:  H E ALEXANDER; G KOCH; I M MOUNTAIN; O VAN DAMME
Journal:  J Exp Med       Date:  1958-10-01       Impact factor: 14.307

9.  Liver microsomes; an integrated morphological and biochemical study.

Authors:  G E PALADE; P SIEKEVITZ
Journal:  J Biophys Biochem Cytol       Date:  1956-03-25

10.  Antibody formation in vitro.

Authors:  M FISHMAN
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more
  41 in total

1.  Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.

Authors:  P Hoops; N E Prather; J Berry; J M Ravel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

2.  Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

3.  Cell-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.

Authors:  M R Venneman; L J Berry
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

4.  Serum-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.

Authors:  M R Venneman; L J Berry
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

5.  Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

6.  The immunogenic activity of ribosomal fractions derived from Brucella abortus.

Authors:  M J Corbel
Journal:  J Hyg (Lond)       Date:  1976-02

7.  Cell-mediated immunity to Vibrio cholerae with ribonucleic acid-protein fractions of V. cholerae L-form lysates.

Authors:  S C Agarwal; T Sundararaj
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

8.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

9.  Effect of erythrocytes treated with enterobacterial common antigen on experimental Salmonella typhimurium infection of mice.

Authors:  E A Gorzynski; S A Krasny
Journal:  Med Microbiol Immunol       Date:  1975-07-02       Impact factor: 3.402

10.  Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.

Authors:  M Riottot; J M Fournier; J Pillot
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.